St. Jude Launches Vascular Imaging Tech in Japan

Medical device maker St. Jude Medical (NYSE: STJ  ) is launching its next-generation coronary vessel imaging technology, the FFR and OCT Ilumien Optis system, in its first market -- Japan.

The Ilumien Optis will help physicians better decide where to place stents in patients according to anatomy and the state of cardiac disease, St. Jude explained in a press release Monday.

The Ilumien Optis offers an upgrade on St. Jude's earlier Ilumien imaging system and comes with a new, state-of-the-art software tool. According to the company, Japanese physicians perform around 245,000 percutaneous coronary interventions per year -- around 80% of which use imaging technology, a market that St. Jude hopes to tap into.

Wakayama Medical University's Dr. Takashi Akasaka was quoted in the company press release as saying, "The Ilumien Optis system enables a higher image resolution, and thus makes it possible for us to analyze difficult anatomical structures, allowing me to focus on diagnostic and treatment strategies. Also, this new analytical tool will be helpful for sizing and placing the stent."

The move is St. Jude's latest attempt to diversify away from the lagging cardiac rhythm management market, especially considering the company's history of trouble over its debrillator leads, such as the recalled Riata.

link


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2310312, ~/Articles/ArticleHandler.aspx, 11/21/2014 10:11:50 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement